Guardant Non Currrent Assets Other vs Current Deferred Revenue Analysis

GH Stock

USD 17.35 0.19 1.11%

Guardant Health financial indicator trend analysis is much more than just examining Guardant Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Guardant Health is a good investment. Please check the relationship between Guardant Health Non Currrent Assets Other and its Current Deferred Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Non Currrent Assets Other vs Current Deferred Revenue

Non Currrent Assets Other vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Guardant Health Non Currrent Assets Other account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between Guardant Health's Non Currrent Assets Other and Current Deferred Revenue is 0.68. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Guardant Health, assuming nothing else is changed. The correlation between historical values of Guardant Health's Non Currrent Assets Other and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Guardant Health are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Non Currrent Assets Other i.e., Guardant Health's Non Currrent Assets Other and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.68

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Guardant Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Tax Provision is increasing as compared to previous years. The Guardant Health's current Issuance Of Capital Stock is estimated to increase to about 517.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	250.7M	293.2M	336.9M	177.0M
Total Revenue	373.7M	449.5M	563.9M	282.4M

Gross Profit Total Revenue

Guardant Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations	Inventory
Total Assets		0.9	0.67	0.85	0.62	-0.19	0.7	0.83	0.74	0.61	-0.73	0.45	0.75	0.87	0.67	0.84	0.9	0.95	0.92	0.74	0.69	0.89	0.87	0.97	0.78	0.76
Short Long Term Debt Total	0.9		0.61	0.95	0.24	-0.19	0.35	0.97	0.71	0.82	-0.84	0.66	0.68	0.82	0.78	0.92	0.84	0.82	0.93	0.8	0.54	0.88	0.95	0.89	0.91	0.84
Other Current Liab	0.67	0.61		0.64	0.32	-0.21	0.35	0.58	0.46	0.28	-0.61	-0.06	0.77	0.8	0.72	0.81	0.6	0.52	0.63	0.53	-0.01	0.71	0.7	0.59	0.68	0.61
Total Current Liabilities	0.85	0.95	0.64		0.18	0.01	0.3	0.99	0.83	0.8	-0.88	0.69	0.63	0.84	0.81	0.92	0.91	0.72	0.97	0.74	0.44	0.9	0.91	0.88	0.95	0.87
Total Stockholder Equity	0.62	0.24	0.32	0.18		-0.15	0.97	0.14	0.32	-0.05	-0.01	-0.16	0.33	0.48	-0.05	0.18	0.47	0.67	0.36	0.23	0.68	0.32	0.18	0.56	0.04	0.07
Other Liab	-0.19	-0.19	-0.21	0.01	-0.15		-0.21	-0.05	0.36	-0.1	-0.03	0.18	-0.18	-0.17	-0.03	-0.16	0.1	-0.21	0.03	-0.45	-0.12	-0.15	-0.17	-0.08	-0.06	0.03
Net Tangible Assets	0.7	0.35	0.35	0.3	0.97	-0.21		0.25	0.44	0.07	-0.12	-0.03	0.38	0.55	0.05	0.28	0.6	0.73	0.47	0.28	0.73	0.43	0.28	0.67	0.16	0.18
Property Plant And Equipment Net	0.83	0.97	0.58	0.99	0.14	-0.05	0.25		0.78	0.87	-0.86	0.74	0.59	0.83	0.79	0.93	0.86	0.71	0.96	0.77	0.48	0.88	0.92	0.85	0.95	0.85
Current Deferred Revenue	0.74	0.71	0.46	0.83	0.32	0.36	0.44	0.78		0.52	-0.78	0.64	0.58	0.63	0.68	0.68	0.95	0.7	0.88	0.41	0.48	0.78	0.71	0.86	0.74	0.79
Net Debt	0.61	0.82	0.28	0.8	-0.05	-0.1	0.07	0.87	0.52		-0.63	0.82	0.23	0.69	0.53	0.77	0.63	0.46	0.77	0.59	0.52	0.65	0.75	0.59	0.82	0.62
Retained Earnings	-0.73	-0.84	-0.61	-0.88	-0.01	-0.03	-0.12	-0.86	-0.78	-0.63		-0.66	-0.82	-0.62	-0.97	-0.86	-0.78	-0.69	-0.84	-0.71	-0.24	-0.91	-0.94	-0.78	-0.94	-1.0
Accounts Payable	0.45	0.66	-0.06	0.69	-0.16	0.18	-0.03	0.74	0.64	0.82	-0.66		0.19	0.34	0.5	0.52	0.59	0.43	0.67	0.49	0.52	0.58	0.62	0.56	0.69	0.66
Cash	0.75	0.68	0.77	0.63	0.33	-0.18	0.38	0.59	0.58	0.23	-0.82	0.19		0.56	0.87	0.73	0.65	0.77	0.65	0.63	0.17	0.81	0.81	0.73	0.7	0.83
Non Current Assets Total	0.87	0.82	0.8	0.84	0.48	-0.17	0.55	0.83	0.63	0.69	-0.62	0.34	0.56		0.6	0.9	0.82	0.69	0.88	0.67	0.49	0.81	0.79	0.8	0.8	0.63
Non Currrent Assets Other	0.67	0.78	0.72	0.81	-0.05	-0.03	0.05	0.79	0.68	0.53	-0.97	0.5	0.87	0.6		0.86	0.69	0.6	0.76	0.68	0.06	0.87	0.91	0.69	0.91	0.96
Other Assets	0.84	0.92	0.81	0.92	0.18	-0.16	0.28	0.93	0.68	0.77	-0.86	0.52	0.73	0.9	0.86		0.81	0.69	0.9	0.74	0.34	0.9	0.96	0.8	0.96	0.86
Long Term Debt	0.9	0.84	0.6	0.91	0.47	0.1	0.6	0.86	0.95	0.63	-0.78	0.59	0.65	0.82	0.69	0.81		0.82	0.97	0.58	0.6	0.88	0.82	0.96	0.82	0.8
Cash And Short Term Investments	0.95	0.82	0.52	0.72	0.67	-0.21	0.73	0.71	0.7	0.46	-0.69	0.43	0.77	0.69	0.6	0.69	0.82		0.81	0.68	0.74	0.81	0.79	0.94	0.65	0.72
Net Receivables	0.92	0.93	0.63	0.97	0.36	0.03	0.47	0.96	0.88	0.77	-0.84	0.67	0.65	0.88	0.76	0.9	0.97	0.81		0.71	0.58	0.92	0.9	0.95	0.91	0.85
Common Stock Shares Outstanding	0.74	0.8	0.53	0.74	0.23	-0.45	0.28	0.77	0.41	0.59	-0.71	0.49	0.63	0.67	0.68	0.74	0.58	0.68	0.71		0.39	0.84	0.78	0.71	0.75	0.72
Short Term Investments	0.69	0.54	-0.01	0.44	0.68	-0.12	0.73	0.48	0.48	0.52	-0.24	0.52	0.17	0.49	0.06	0.34	0.6	0.74	0.58	0.39		0.45	0.42	0.67	0.32	0.28
Long Term Debt Total	0.89	0.88	0.71	0.9	0.32	-0.15	0.43	0.88	0.78	0.65	-0.91	0.58	0.81	0.81	0.87	0.9	0.88	0.81	0.92	0.84	0.45		0.94	0.9	0.93	0.93
Non Current Liabilities Total	0.87	0.95	0.7	0.91	0.18	-0.17	0.28	0.92	0.71	0.75	-0.94	0.62	0.81	0.79	0.91	0.96	0.82	0.79	0.9	0.78	0.42	0.94		0.85	0.96	0.94
Capital Surpluse	0.97	0.89	0.59	0.88	0.56	-0.08	0.67	0.85	0.86	0.59	-0.78	0.56	0.73	0.8	0.69	0.8	0.96	0.94	0.95	0.71	0.67	0.9	0.85		0.79	0.8
Capital Lease Obligations	0.78	0.91	0.68	0.95	0.04	-0.06	0.16	0.95	0.74	0.82	-0.94	0.69	0.7	0.8	0.91	0.96	0.82	0.65	0.91	0.75	0.32	0.93	0.96	0.79		0.93
Inventory	0.76	0.84	0.61	0.87	0.07	0.03	0.18	0.85	0.79	0.62	-1.0	0.66	0.83	0.63	0.96	0.86	0.8	0.72	0.85	0.72	0.28	0.93	0.94	0.8	0.93

Click cells to compare fundamentals

Guardant Health Account Relationship Matchups

Guardant Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	962.5M	2.3B	2.2B	1.6B	1.8B	1.4B
Short Long Term Debt Total	33.3M	847.9M	1.4B	1.4B	1.4B	685.2M
Other Current Liab	37.1M	44.3M	152.9M	(21.9M)	108.3M	113.7M
Total Current Liabilities	72.7M	66.8M	194.7M	193.2M	205.9M	112.0M
Total Stockholder Equity	798.4M	1.3B	645.0M	60.2M	158.7M	150.7M
Other Liab	8.6M	1.5M	3.9M	9.2M	8.3M	6.7M
Net Tangible Assets	779.7M	1.3B	627.5M	45.2M	51.9M	49.3M
Property Plant And Equipment Net	72.8M	100.1M	313.9M	341.9M	302.7M	163.8M
Current Deferred Revenue	12.3M	8.6M	11.3M	17.4M	18.0M	12.2M
Net Debt	(110.0M)	14.9M	868.7M	1.2B	220.2M	274.0M
Retained Earnings	(352.8M)	(606.6M)	(1.0B)	(1.7B)	(2.1B)	(2.0B)
Accounts Payable	16.2M	7.3M	17.6M	175.8M	51.7M	39.5M
Cash	143.2M	833.0M	492.2M	141.6M	1.1B	1.2B
Non Current Assets Total	365.2M	383.4M	1.1B	418.4M	439.3M	402.7M
Non Currrent Assets Other	4.9M	17.2M	60.9M	61.5M	124.2M	130.4M
Other Assets	4.9M	17.2M	60.9M	36.5M	41.9M	44.0M
Cash And Short Term Investments	522.8M	1.8B	932.7M	1.0B	1.2B	847.8M
Net Receivables	48.0M	53.3M	97.7M	97.3M	88.8M	60.1M
Common Stock Shares Outstanding	90.6M	97.5M	101.3M	102.2M	112.0M	92.9M
Short Term Investments	379.6M	961.9M	440.5M	869.6M	35.1M	33.3M
Liabilities And Stockholders Equity	962.5M	2.3B	2.2B	1.6B	1.8B	1.4B
Non Current Liabilities Total	41.8M	849.4M	1.4B	1.4B	1.4B	1.5B
Capital Surpluse	1.2B	1.9B	1.7B	1.7B	2.0B	1.1B
Capital Lease Obligations	40.4M	41.6M	226.1M	231.9M	213.8M	224.5M
Inventory	15.2M	22.7M	30.7M	51.6M	61.9M	65.0M
Other Current Assets	11.4M	17.5M	53.1M	31.5M	27.7M	20.6M
Other Stockholder Equity	1.2B	1.9B	1.7B	1.7B	2.3B	1.3B
Total Liab	114.5M	916.2M	1.6B	1.5B	1.6B	1.7B
Property Plant And Equipment Gross	72.8M	100.1M	313.9M	341.9M	430.0M	451.5M
Total Current Assets	597.4M	1.9B	1.1B	1.2B	1.3B	956.1M
Accumulated Other Comprehensive Income	1.1M	2.7M	(4.8M)	(19.5M)	(3.7M)	(3.9M)
Non Current Liabilities Other	8.6M	43.1M	3.9M	9.2M	96.0M	100.8M
Short Term Debt	7.1M	6.6M	12.9M	21.9M	28.0M	29.3M
Property Plant Equipment	72.8M	62.8M	313.9M	167.9M	193.1M	106.4M
Net Invested Capital	798.4M	2.1B	1.8B	1.2B	1.3B	1.2B
Net Working Capital	524.6M	1.8B	919.4M	998.4M	1.1B	950.8M
Intangible Assets	15.4M	16.2M	14.2M	11.7M	9.0M	13.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:

How To Invest In Guardant

Details

Is Guardant Stock a good investment?

Details

What is Guardant Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Commodity Directory Find actively traded commodities issued by global exchanges
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.28)

Revenue Per Share

5.036

Quarterly Revenue Growth

0.222

Return On Assets

(0.18)

Return On Equity

(4.38)

The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guardant Non Currrent Assets Other vs Current Deferred Revenue Analysis

Non Currrent Assets Other vs Current Deferred Revenue

Non Currrent Assets Other vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Non Currrent Assets Other

Current Deferred Revenue

Guardant Health fundamental ratios Correlations

Guardant Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Guardant Health fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Guardant Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 0.99	Total Current Liabilities
Capital Surpluse	+ 0.97	Total Assets
Property Plant And Equipment Net	+ 0.97	Short Long Term Debt Total
Net Receivables	+ 0.97	Total Current Liabilities
Net Tangible Assets	+ 0.97	Total Stockholder Equity
Net Receivables	+ 0.97	Long Term Debt

Inventory	- 1.0	Retained Earnings
Non Currrent Assets Other	- 0.97	Retained Earnings
Capital Lease Obligations	- 0.94	Retained Earnings
Non Current Liabilities Total	- 0.94	Retained Earnings
Long Term Debt Total	- 0.91	Retained Earnings
Retained Earnings	- 0.88	Total Current Liabilities